Literature DB >> 7614964

Usefulness of culture in the diagnosis of Clostridium difficile infection.

F Bond1, G Payne, S P Borriello, H Humphreys.   

Abstract

Between January and April 1993, culture for Clostridium difficile and a faecal cytotoxin assay were performed on 500 selected specimens. Isolates from culture-positive patients from whom faecal samples were cytotoxin negative were also examined in vitro for cytotoxin production. The significance of a positive culture result in the absence of faecal cytotoxin was assessed. Forty-one of the 500 specimens were toxin positive. In only 25 of these was Clostridium difficile examination specifically requested. Six of nine culture-positive cytotoxin-negative patients (11 specimens) had recently received antibiotics. In four of these, Clostridium difficile was considered to be of possible clinical significance. Culture and in vitro determination of toxin production of isolates may aid in the diagnosis of some additional cases, but cytotoxin detection remains the single optimal routine laboratory method for diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7614964     DOI: 10.1007/BF02310360

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Selective criteria for the microbiological examination of faecal specimens.

Authors:  R A Bowman; J M Bowman; S A Arrow; T V Riley
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

2.  Clostridium difficile in the elderly.

Authors:  S P Borriello; F E Barclay
Journal:  J Infect       Date:  1991-05       Impact factor: 6.072

3.  Non-radioactive restriction fragment length polymorphism (RFLP) typing of Clostridium difficile.

Authors:  R A Bowman; G L O'Neill; T V Riley
Journal:  FEMS Microbiol Lett       Date:  1991-04-15       Impact factor: 2.742

Review 4.  Clostridium difficile infection: responses, relapses and re-infections.

Authors:  M H Wilcox; R C Spencer
Journal:  J Hosp Infect       Date:  1992-10       Impact factor: 3.926

5.  Comparison of three enzyme immunoassays, a cytotoxicity assay, and toxigenic culture for diagnosis of Clostridium difficile-associated diarrhea.

Authors:  F Barbut; C Kajzer; N Planas; J C Petit
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

Review 6.  Clostridium difficile: clinical disease and diagnosis.

Authors:  F C Knoop; M Owens; I C Crocker
Journal:  Clin Microbiol Rev       Date:  1993-07       Impact factor: 26.132

7.  Comparison of four commercially available rapid enzyme immunoassays with cytotoxin assay for detection of Clostridium difficile toxin(s) from stool specimens.

Authors:  C S Merz; C Kramer; M Forman; L Gluck; K Mills; K Senft; I Steiman; N Wallace; P Charache
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Application of rejection criteria for stool cultures for bacterial enteric pathogens.

Authors:  K Fan; A J Morris; L B Reller
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

9.  Latex particle agglutination for detecting and identifying Clostridium difficile.

Authors:  R A Bowman; S A Arrow; T V Riley
Journal:  J Clin Pathol       Date:  1986-02       Impact factor: 3.411

10.  Gastrointestinal carriage rate of Clostridium difficile in elderly, chronic care hospital patients.

Authors:  C Cefai; T S Elliott; K W Woodhouse
Journal:  J Hosp Infect       Date:  1988-05       Impact factor: 3.926

View more
  8 in total

1.  Laboratory diagnosis of Clostridium difficile-associated diarrhea and colitis: usefulness of Premier Cytoclone A+B enzyme immunoassay for combined detection of stool toxins and toxigenic C. difficile strains.

Authors:  A Lozniewski; C Rabaud; E Dotto; M Weber; F Mory
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

2.  Usefulness of culture in the diagnosis of Clostridium difficile infection.

Authors:  T V Riley; R A Bowman; C L Golledge
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-12       Impact factor: 3.267

3.  Comparison of four laboratory tests for diagnosis of Clostridium difficile-associated diarrhea.

Authors:  J Jacobs; B Rudensky; J Dresner; A Berman; M Sonnenblick; Y van Dijk; A M Yinnon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

4.  Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.

Authors:  H Rüssmann; K Panthel; R-C Bader; C Schmitt; R Schaumann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

5.  Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy.

Authors:  S S Johal; J Hammond; K Solomon; P D James; Y R Mahida
Journal:  Gut       Date:  2004-05       Impact factor: 23.059

6.  Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile.

Authors:  Megan E Reller; Clara A Lema; Trish M Perl; Mian Cai; Tracy L Ross; Kathleen A Speck; Karen C Carroll
Journal:  J Clin Microbiol       Date:  2007-09-05       Impact factor: 5.948

7.  Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea.

Authors:  L R Peterson; P J Kelly; H A Nordbrock
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

8.  Steroid-refractory ulcerative colitis treated with corticosteroids, metronidazole and vancomycin: a case report.

Authors:  Jonathan Miner; M Monem Gillan; Philip Alex; Michael Centola
Journal:  BMC Gastroenterol       Date:  2005-01-24       Impact factor: 3.067

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.